• 首页期刊简介编委会刊物订阅专栏专刊电子刊学术动态联系我们English
引用本文:周婧,应淑颖,茹仁萍.特利加压素致皮肤坏死的不良反应分析[J].中国现代应用药学,2019,36(23):2970-2974.
ZHOU Jing,YING Shuying,RU Renping.Analysis of Adverse Reactions of Terlipressin on Skin Necrosis[J].Chin J Mod Appl Pharm(中国现代应用药学),2019,36(23):2970-2974.
【打印本页】   【HTML】   【下载PDF全文】   查看/发表评论  【EndNote】   【RefMan】   【BibTex】
←前一篇|后一篇→ 过刊浏览    高级检索
本文已被:浏览 1952次   下载 920 本文二维码信息
码上扫一扫!
分享到: 微信 更多
特利加压素致皮肤坏死的不良反应分析
周婧1, 应淑颖2, 茹仁萍1
1.杭州市西溪医院药剂科, 杭州 310023;2.杭州市西溪医院ICU病区, 杭州 310023
摘要:
目的 探讨特利加压素致皮肤坏死不良反应的发生规律、危险因素等,为临床合理使用该药提供参考。方法 报道1例特利加压素所致的皮肤坏死,并检索相关文献,对报道的案例进行分类统计分析。结果 特利加压素引起的皮肤坏死以男性为主(76.67%),年龄主要分布在50岁以上(73.33%),不良反应高发时间为用药前5 d(83.33%),以躯干、四肢多见。低血容量、肥胖、酒精性肝病肝硬化、合并使用血管活性药物等可能为特利加压素引起皮肤缺血的高危因素。结论 临床使用中应重视特利加压素引起皮肤坏死的不良反应,应用过程要密切关注,及早发现,及早处理。
关键词:  特利加压素  皮肤坏死  不良反应
DOI:10.13748/j.cnki.issn1007-7693.2019.23.017
分类号:R969.3
基金项目:
Analysis of Adverse Reactions of Terlipressin on Skin Necrosis
ZHOU Jing1, YING Shuying2, RU Renping1
1.Department of Pharmacy, Xixi Hospital of Hangzhou, Hangzhou 310023, China;2.Department of ICU, Xixi Hospital of Hangzhou, Hangzhou 310023, China
Abstract:
OBJECTIVE To study the general regularity and risk factors of adverse drug reactions to skin necrosis induced by terlipressin, to provide reference for the rational use of drug in clinical. METHODS Reported one case of skin necrosis caused by terlipressin, searched related literature and statistical analysis. RESULTS The skin necrosis caused by terlipressin was mainly in males(76.67%) and over 50 years old(73.33%), the time of high incidence of adverse reactions was 5 d before medication(83.33%), mainly in trunk and limbs. Low blood volume, obesity, alcoholic liver cirrhosis, combined use of vasoactive drugs may high risk factors of skin ischemia caused by terlipressin. CONCLUSION The clinical use of terlipressin should pay attention to the adverse reactions caused by necrosis of the skin, and pay close attention to the application process, early detection and early treatment.
Key words:  terlipressin  skin necrosis  adverse reaction
扫一扫关注本刊微信